Researchers find artificial pancreas useful for type 2 diabetes patients

Cambridge scientists have successfully trialled an artificial pancreas for use by patients living with type 2 diabetes. The device - powered by an algorithm developed at the University of Cambridge - doubled the amount of time patients were in the target range for glucose compared to standard treatment and halved the time spent experiencing high glucose levels.

Around 415 million people worldwide are estimated to be living with type 2 diabetes, which costs around $760 billion in annual global health expenditure. According to Diabetes UK, in the UK alone, more than 4.9 million people have diabetes, of whom 90% have type 2 diabetes, and this is estimated to cost the NHS £10bn per year.

Reference:

Daly, A. B., Boughton, (2023), Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial. Nature Medicine. DOI: 10.1038/s41591-022-02144-z